Keywords: hgs, hgs-etr1, velcade, enters, ph, ii, mm

HGS' HGS-ETR1+Velcade enters Ph II MM trial

Article | 31 July 2006

Print This

USA-based Human Genome Sciences has initiated dosing of patients in a randomized Phase II clinical trial of its anticancer drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in